Business
Sensus Healthcare to Participate in the 37th Annual ROTH Conference
BOCA RATON, Fla., March 13, 2025--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces it will be participating in Roth Capital’s 37th Annual ROTH Conference, being held March 17-18 in Dana Point, California. Management will be holding one-on-one meetings with registered investors during the conference.
About this update from Sensus Healthcare, Inc.
[{"type":"text","content":"BOCA RATON, Fla., March 13, 2025--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces it will be participating in Roth Capital’s 37th Annual ROTH Conference, being held March 17-18 in Dana Point, California. Management will be holding one-on-one meetings with registered investors during the conference.","length":493,"tagName":"p"},{"type":"text","content":"Registered attendees who would like to schedule a meeting with Sensus Healthcare management should contact their ROTH representative or Tirth Patel at [email protected].","length":179,"tagName":"p"},{"type":"text","content":"About Sensus Healthcare","length":23,"tagName":"p"},{"type":"text","content":"Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.","length":548,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20250313048513/en/","length":98,"tagName":"p"},{"type":"text","content":"Contacts","length":8,"tagName":"p"},{"type":"text","content":"Alliance Advisors IR Tirth T. [email protected] 212-201-6614","length":78,"tagName":"p"}]